lovastatin has been researched along with Disseminated Superficial Actinic Porokeratosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 8 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buhle, AC; Fagan, KK; Grider, DJ; Johnson, NM | 1 |
| Barton, V; Drohan, A; Elston, DM; Gregoski, MJ; Lateef, A; Santa Lucia, G; Snyder, A | 1 |
| Casale, F; Dong, J; Peach, A; Walters, N | 1 |
| Atzmony, L; Choate, KA; Hamilton, C; Leventhal, JS; Lim, YH; Paller, AS; Wagner, A | 1 |
| Heymann, WR | 1 |
| Abbott, J; Blue, E; Bowen, A; Cipriano, SD | 1 |
| Genovese, C; Genovese, G; Maronese, CA; Marzano, AV | 1 |
| Biedermann, T; Tomsitz, D | 1 |
1 review(s) available for lovastatin and Disseminated Superficial Actinic Porokeratosis
| Article | Year |
|---|---|
Efficacy of Topical Cholesterol and Statin Combination Therapy in the Treatment of Porokeratosis: A Systematic Review and Meta-Analysis.
Topics: Cholesterol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Porokeratosis; Simvastatin | 2023 |
1 trial(s) available for lovastatin and Disseminated Superficial Actinic Porokeratosis
| Article | Year |
|---|---|
Safety and Efficacy of Topical Lovastatin Plus Cholesterol Cream vs Topical Lovastatin Cream Alone for the Treatment of Disseminated Superficial Actinic Porokeratosis: A Randomized Clinical Trial.
Topics: Adult; Cholesterol; COVID-19; Emollients; Female; Humans; Lovastatin; Middle Aged; Pandemics; Porokeratosis; Treatment Outcome | 2023 |
6 other study(ies) available for lovastatin and Disseminated Superficial Actinic Porokeratosis
| Article | Year |
|---|---|
Treating linear porokeratosis with topical lovastatin/cholesterol cream.
Topics: Cholesterol; Humans; Keratinocytes; Lovastatin; Porokeratosis | 2022 |
Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy.
Topics: Administration, Cutaneous; Adult; Anticholesteremic Agents; Carboxy-Lyases; Child, Preschool; Cholesterol; Drug Combinations; Genotype; Humans; Lovastatin; Middle Aged; Mutation; Ointments; Phosphotransferases (Phosphate Group Acceptor); Porokeratosis; Young Adult | 2020 |
Shifting from expectant observation to active intervention.
Topics: Cholesterol; Humans; Lovastatin; Porokeratosis; Watchful Waiting | 2020 |
Linear porokeratosis with bone abnormalities treated with compounded topical 2% cholesterol/2% lovastatin ointment.
Topics: Adolescent; Cholesterol; Epidermis; Female; Humans; Lovastatin; Ointments; Porokeratosis | 2021 |
Refractory disseminated superficial actinic porokeratosis effectively treated with cholesterol/lovastatin cream: A case report.
Topics: Cholesterol; Humans; Lovastatin; Ointments; Porokeratosis | 2021 |
Successful treatment of disseminated superficial actinic porokeratosis with topical 2% cholesterol/ 2% lovastatin cream: a case series with 7 patients.
Topics: Cholesterol; Emollients; Humans; Lovastatin; Porokeratosis | 2022 |